. . . . . . . "[Here, we report for the first time that RLX has anti-cancer property against panel of human cancer cell lines and most potent activity was found against HCT-116 cells with IC50 value of 12\uFFFD?M and have further investigated the involvement of NF?B and caspase-3 in RLX action in CRC apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:12+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .